Sugar utilization by microglia in Alzheimer's disease

Area of Science:

• Neuroscience
• Immunology
• Metabolic Disorders

Background:

• Diabetes mellitus is a significant risk factor for Alzheimer's disease (AD) pathogenesis.
• Microglia, the brain's primary immune cells, exhibit metabolic alterations during neuroinflammation characteristic of AD.
• The influence of dietary carbohydrate sources on AD-related microglial changes is not well understood.

Purpose of the Study:

• To investigate the impact of different dietary carbohydrate sources (glucose vs. fructose) on microglial gene expression and reactivity in the context of Alzheimer's disease pathology.
• To explore the role of sugar transporters in microglial metabolic adaptation to varying sugar availabilities.

Main Methods:

• Analysis of existing gene expression data to identify changes in sugar transporter expression (SLC2A1, SLC2A5).
• In vitro studies using N9 mouse microglia cell line cultured in glucose- or fructose-supplemented media and stimulated with lipopolysaccharide (LPS), followed by RNA-sequencing.
• In vivo studies using 5XFAD transgenic mice fed equicaloric diets containing dextrose or fructose, with subsequent amyloid plaque burden and microglial response assessment via confocal microscopy.

Main Results:

• Gene expression analysis revealed differential regulation of sugar transporters, with increased glucose transporter (Slc2a1) and decreased fructose transporter (Slc2a5) expression.
• RNA-sequencing of microglia showed significant gene expression changes between control and sugar-supplemented media, and distinct profiles between glucose and fructose conditions.
• In vivo, while amyloid plaque burden and overall microglial response were similar across diets, a notable difference in microglial reactivity was observed between dextrose- and fructose-fed mice.

Conclusions:

• Microglia preferentially express specific sugar transporters, indicating a tailored metabolic response to available carbohydrates.
• The source of dietary sugar (glucose vs. fructose) may modulate microglial reactivity and inflammatory responses in the presence of Alzheimer's disease-related pathology.
• These findings highlight a potential link between dietary composition and neuroimmune function in AD, warranting further investigation.